Search research articles
Contact Us
Filters
Showing results (31-40 of 67) with videos related to
Page
of 7
Sort By:
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
May 9, 2025
Demand- Versus Supply-Side Policies in Market Penetration of Biosimilars: Which is More Effective?
Gyeongseon Shin, Heejin Han, Gyeyoung Choi, et al.
International Journal of Environmental Research and Public Health
|
September 9, 2022
The Impact of Payment Scheme Changes on Medication Adherence and Persistence of Patients Diagnosed with Depression in Korea
Gyeongseon Shin, Bohwa Jang, Green Bae, et al.
International Journal of Clinical Pharmacy
|
September 16, 2019
Utilization of oral anticoagulants in Korean nonvalvular atrial fibrillation patients
Hye-Yoon Song, Kyung-Bok Son, Ju-Young Shin, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
December 8, 2023
Is the Availability of Biosimilar Adalimumab Associated with Budget Savings? A Difference-in-Difference Analysis of 14 Countries
Hyunjung Woo, Gyeongseon Shin, Donghwan Lee, et al.
International Journal of Environmental Research and Public Health
|
April 30, 2021
Medication Adherence and Persistence of Open-Angle Glaucoma Patients in Korea: A Retrospective Study Using National Health Insurance Claims Data
Yunjeong Jang, Donghyun Jee, Donghwan Lee, et al.
BMJ Open
|
May 19, 2017
Modeling lifetime costs and health outcomes attributable to secondhand smoke exposure at home among Korean adult women
Jiyae Lee, Ah Ram Han, Dalwoong Choi, et al.
Clinical and Molecular Hepatology
|
October 4, 2024
Self-testing strategy to eliminate hepatitis C as per World Health Organization's goal: Analysis of disease burden and cost-effectiveness
Gyeongseon Shin, Beom Kyung Kim, SeungJin Bae, et al.
Frontiers in Pharmacology
|
August 1, 2020
Uptake of Biosimilar Infliximab in the UK, France, Japan, and Korea: Budget Savings or Market Expansion Across Countries?
Yujeong Kim, Hye-Young Kwon, Brian Godman, et al.
Frontiers in Pharmacology
|
November 27, 2025
A comparative analysis of biologics market dynamics in 12 countries: (Bio)similar and sustainability
Younghyun Song, Gyeongseon Shin, Gyeyoung Choi, et al.
Toxicological Research
|
January 27, 2018
Mental Stress from Animal Experiments: a Survey with Korean Researchers
Minji Kang, AhRam Han, Da-Eun Kim, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 67) with videos related to
Sort By:
Page
of 7
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
May 9, 2025
Demand- Versus Supply-Side Policies in Market Penetration of Biosimilars: Which is More Effective?
Gyeongseon Shin, Heejin Han, Gyeyoung Choi, et al.
International Journal of Environmental Research and Public Health
|
September 9, 2022
The Impact of Payment Scheme Changes on Medication Adherence and Persistence of Patients Diagnosed with Depression in Korea
Gyeongseon Shin, Bohwa Jang, Green Bae, et al.
International Journal of Clinical Pharmacy
|
September 16, 2019
Utilization of oral anticoagulants in Korean nonvalvular atrial fibrillation patients
Hye-Yoon Song, Kyung-Bok Son, Ju-Young Shin, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
December 8, 2023
Is the Availability of Biosimilar Adalimumab Associated with Budget Savings? A Difference-in-Difference Analysis of 14 Countries
Hyunjung Woo, Gyeongseon Shin, Donghwan Lee, et al.
International Journal of Environmental Research and Public Health
|
April 30, 2021
Medication Adherence and Persistence of Open-Angle Glaucoma Patients in Korea: A Retrospective Study Using National Health Insurance Claims Data
Yunjeong Jang, Donghyun Jee, Donghwan Lee, et al.
BMJ Open
|
May 19, 2017
Modeling lifetime costs and health outcomes attributable to secondhand smoke exposure at home among Korean adult women
Jiyae Lee, Ah Ram Han, Dalwoong Choi, et al.
Clinical and Molecular Hepatology
|
October 4, 2024
Self-testing strategy to eliminate hepatitis C as per World Health Organization's goal: Analysis of disease burden and cost-effectiveness
Gyeongseon Shin, Beom Kyung Kim, SeungJin Bae, et al.
Frontiers in Pharmacology
|
August 1, 2020
Uptake of Biosimilar Infliximab in the UK, France, Japan, and Korea: Budget Savings or Market Expansion Across Countries?
Yujeong Kim, Hye-Young Kwon, Brian Godman, et al.
Frontiers in Pharmacology
|
November 27, 2025
A comparative analysis of biologics market dynamics in 12 countries: (Bio)similar and sustainability
Younghyun Song, Gyeongseon Shin, Gyeyoung Choi, et al.
Toxicological Research
|
January 27, 2018
Mental Stress from Animal Experiments: a Survey with Korean Researchers
Minji Kang, AhRam Han, Da-Eun Kim, et al.
Page
of 7